Showing results (261-270 of 413) with videos related to

Sort By:
Pageof 42
Cancer Epidemiology|June 25, 2018
The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trialsJoseph M Unger, William E Barlow, Catherine M Tangen, et al.
Cancer Causes & Control : CCC|July 20, 2012
Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Charlotte A Gaydos, et al.
International Journal of General Medicine|July 16, 2011
Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study of a US populationSun Hee Rim, Ingrid J Hall, Megan E Fairweather, et al.
JCO Precision Oncology|November 5, 2024
DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 TrialGopa Iyer, Catherine M Tangen, Michal Sarfaty, et al.
World Journal of Urology|October 21, 2010
Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinionsScott D Ramsey, Steven B Zeliadt, Catherine R Fedorenko, et al.
The New England Journal of Medicine|May 28, 2004
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliterIan M Thompson, Donna K Pauler, Phyllis J Goodman, et al.
Journal of the National Cancer Institute|February 25, 2014
Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer riskAlan R Kristal, Amy K Darke, J Steven Morris, et al.
The Journal of Urology|August 28, 2012
Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346)Catherine M Tangen, Maha H A Hussain, Celestia S Higano, et al.
Urologic Oncology|September 24, 2013
Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs. stapling deviceIan M Thompson, Stephen F Kappa, Todd M Morgan, et al.
JAMA Network Open|August 6, 2024
Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical TrialShuchi Gulati, Catherine Tangen, Christopher W Ryan, et al.
Pageof 42